Nancy Sohler to Naloxone
This is a "connection" page, showing publications Nancy Sohler has written about Naloxone.
Connection Strength
0.266
-
Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R. The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation. J Acquir Immune Defic Syndr. 2011 Mar 01; 56 Suppl 1:S76-82.
Score: 0.086
-
Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr. 2011 Mar 01; 56 Suppl 1:S83-90.
Score: 0.086
-
Cunningham C, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil R, Sohler N. Buprenorphine treatment in an urban community health center: what to expect. Fam Med. 2008 Jul-Aug; 40(7):500-6.
Score: 0.072
-
Whitley SD, Sohler NL, Kunins HV, Giovanniello A, Li X, Sacajiu G, Cunningham CO. Factors associated with complicated buprenorphine inductions. J Subst Abuse Treat. 2010 Jul; 39(1):51-7.
Score: 0.021